Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma

Published:2022-05-11 Issue:9 Volume:29 Page:5666-5678
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Wang Yanan,Chen Ya,Yang Zhengyu,Qian Fangfei,Hu Minjuan,Lu Jun,Zhang Yanwei,Zhang Wei,Wang Kai,Han Baohui

Funder

the project of Science and Technology Commission of Shanghai Municipality

the foundation of Shanghai Shenkang Hospital Development Center Emerging Frontier Technology Joint Research Project

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-022-11610-4.pdf

Reference36 articles.

1. Travis WD. Advances in neuroendocrine lung tumors. Ann Oncol. Oct 2010;21 Suppl 7:vii65-71.

2. Eichhorn F, Dienemann H, Muley T, Warth A, Hoffmann H. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg. 2015;99(3):983–9.

3. Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243–60.

4. Ettinger DS, Aisner DL, Wood DE, et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. J Natl Compr Canc Netw. Jul 2018;16(7):807-821.

5. Naidoo J, Santos-Zabala ML, Iyriboz T, et al. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes. Clin Lung Cancer. 2016;17(5):e121–9.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma;The Annals of Thoracic Surgery;2024-08

2. Efficacy and safety of immunotherapy plus chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma;2024-02-13

3. Efficacy and safety of immune checkpoint inhibitors in lung large-cell neuroendocrine carcinoma;Journal of Thoracic Disease;2023-08

4. ASO Author Reflections: Pure and Combined Surgically Resected Large Cell Neuroendocrine Carcinoma of Lung: Could They be Evaluated as a Single Entity?;Annals of Surgical Oncology;2022-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3